Author(s)

Zhongxia Li¹, Jing Tan^2*, Xiaoyan Yang³, Hui Zhou¹, Xia Xu¹, Dingxi Zhu¹, Jin Luo²

¹Department of Dermatology, Jingzhou First People’s Hospital, Jingzhou, China.
²Department of Oncology, Jingzhou First People’s Hospital, Jingzhou, China.
³Department of General Medicine, Jingzhou First People’s Hospital, Jingzhou, China.

Objective: In the Healthy Child Action Enhancement Program (2021-2025), it is proposed to ensure the safety and health of newborns and to promote high-quality development of health. Our department established risk assessment criteria for medical adhesives in neonates by applying the best evidence in the management program for the reduction of medical adhesive-associated skin injuries in neonates, in terms of the use and removal of adhesives. Methods: A systematic search and quality assessment of topics related to medical adhesive-related skin injury in neonates was conducted to summarize the best evidence and to conduct a quality review in the neonatal unit. Results: After 2 rounds of review, medical and nursing staff in the neonatal unit had a 98% compliance rate for the knowledge of neonatal medical adhesive-related skin injury and a satisfactory compliance rate for the other 9 indicators; after the application of the evidence, the incidence of neonatal medical adhesive-related skin injury was significantly lower than that before the application of the evidence, and the differences were statistically significant (P < 0.05). Conclusion: The application of the best evidence-based management program in neonatal medical adhesive-associated skin injury can reduce the incidence of neonatal medical adhesive-associated skin injury, reduce neonatal infections, and improve the integrity of the protective skin barrier in neonates.

Evidence-Based, Nursing Management, Neonates, Medical Adhesive-Related Skin Injury, Satisfaction

Li, Z.X., Tan, J.,Yang, X.Y., Zhou, H., Xu, X., Zhu, D.X. and Luo, J. (2025) Application of Best Evidence-Based in Neonatal Medical Adhesive-Related Skin Injuries. Journal of Biosciences and Medicines, 13, 320-329. doi: 10.4236/jbm.2025.132024.